Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Gastroenterology

• Publication date

  1988-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0016-5085(88)90379-4PMID 2844622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamics of hepatic glycosaminoglycan accumulation in murine Schistosoma japonicum infection.

  1986cited by this paper
• Hemochromatosis: Precirrhotic therapy restores normal life expectancy

  1986cited by this paper
• Hepatitis b virus dna in hepatitis b surface antigen negative hepatocellular carcinoma patients

  1985cited by this paper
• Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.

  1985cited by this paper
• Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

  1985cited by this paper
• Genetic Hemochromatosis

  1984cited by this paper
• Idiopathic hemochromatosis, an interim report.

  1980cited by this paper
• Hepatoma developing in hemochromatosis in spite of adequate treatment by multiple phlebotomies

  1971cited by this paper
• Reversal of "cirrhosis" in idiopathic haemochromatosis following long-term intensive venesection therapy.

  1970cited by this paper
• Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients.

  1969cited by this paper
• The treatment of hemochromatosis by phlebotomy.

  1966cited by this paper
• HEPATOMA DEVELOPING IN TREATED HÆMOCHRO–MATOSIS: REPORT OF A CASE

  1961cited by this paper

• Ferroptosis and cancer: when iron turns against tumors

  2025cites this paper
• TSAT-Urated Insights: Clarifying the Complexities of Hereditary Hemochromatosis and Its Guidelines

  2024cites this paper
• EASL Clinical Practice Guidelines on haemochromatosis.

  2022cites this paper
• Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.

  2021cites this paper
• Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review

  2021cites this paper
• Stellate Cells and Fibrosis

  2020cites this paper
• Fibrosis reversal after hepatitis C virus elimination

  2019cites this paper
• ACG Clinical Guideline: Hereditary Hemochromatosis

  2019cites this paper
• 4 – Disorders of Iron Overload

  2018cites this paper
• 1 – Structure, Function, and Responses to Injury

  2018cites this paper
• Haemochromatosis: a clinical update for the practising physician

  2018cites this paper
• Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation

  2016cites this paper
• 1 ROLE OF AETIOLOGY IN THE PROGRESSION , REGRESSION , AND PARENCHYMAL REMODELLING OF LIVER DISEASE IMPLICATIONS FOR LIVER BIOPSY INTERPRETATION THE INTERNATIONAL LIVER PATHOLOGY STUDY GROUP

  2016cites this paper
• Reviews of Physiology, Biochemistry and Pharmacology, Vol. 172

  2016cites this paper
• ROLE OF AETIOLOGY IN THE PROGRESSION, REGRESSION, AND PARENCHYMAL

  2016cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations

  2016cites this paper
• Liver Fibrosis Reversion After Suppression of Hepatitis B Virus.

  2016cites this paper
• Hepatic fibrosis and cirrhosis

  2015cites this paper
• Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies.

  2013cites this paper
• Contribution à la description phénotypique et à l'étude des patients atteints d'hémochromatose HFE

  2013cites this paper
• MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.

  2013cites this paper
• ADVANCES IN TRANSLATIONAL SCIENCE

  2012cites this paper
• Hepatocellular Carcinoma in Non-cirrhotic Liver Without Evidence of Iron Overload in a Patient with Primary Hemochromatosis. Review

  2012cites this paper
• Chapter 5 – Hepatic Fibrosis and Cirrhosis

  2012cites this paper
• Risk factors of hepatocellular carcinoma--current status and perspectives.

  2012cites this paper
• 5 – Disorders of iron overload

  2012cites this paper
• 1 – Anatomy, pathophysiology and basic mechanisms of disease

  2012cites this paper
• Aetiology and Pathophysiology of Chronic Liver Disorders

  2012cites this paper
• Liver transplantation to treat suspected hepatocellular carcinoma in iron-free foci in congenital hemochromatosis: case report.

  2011cites this paper
• Gene–Environmental Interactions and Susceptibility to Liver Cancer

  2010cites this paper
• Histopathological Scoring Systems

  2010cites this paper
• Hepatic iron overload and hepatocellular carcinoma.

  2009cites this paper
• HEMOCHROMATOSIS AND CANCER

  2009cites this paper
• Role of iron in carcinogenesis: Cancer as a ferrotoxic disease

  2009cites this paper
• The global impact of hepatic fibrosis and end-stage liver disease.

  2008cites this paper
• Maß und Zahl in der Hepatopathologie

  2008cites this paper
• Current and future anti-fibrotic therapies for chronic liver disease.

  2008cites this paper
• Metabolic disorders and storage diseases

  2008cites this paper
• Hepatocellular carcinoma in a noncirrhotic patient with hereditary hemochromatosis.

  2007cites this paper
• Patterns of histological change in liver disease: my approach to ‘medical’ liver biopsy reporting

  2007cites this paper
• Iron storage disease: facts, fiction and progress.

  2007cites this paper
• Hepatocellular Carcinoma Associated with Hereditary Hemochromatosis Occurring in Non-Cirrhotic Liver

  2006cites this paper
• Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases

  2006cites this paper
• Iron‐free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron

  2006cites this paper
• Epidemiology of primary and secondary liver cancers.

  2006cites this paper
• Hepatocellular carcinoma caused by iron overload: a possible mechanism of direct hepatocarcinogenicity.

  2006cites this paper
• Surgery for Hepatocellular Carcinoma Arising in Hereditary Hemochromatosis

  2006cites this paper
• The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.

  2006cites this paper
• Etiology and Epidemiology of Hepatocellular Carcinoma

  2005cites this paper
• Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.

  2005cites this paper
• Overall treatment effect estimates " and their standard errorsb

  2005cites this paper
• Pathology of Hepatic Iron Overload

  2005cites this paper
• Antifibrotic therapy in chronic liver disease.

  2005cites this paper
• Iron and liver cancer.

  2003cites this paper
• Hepatocellular carcinoma associated with secondary haemochromatosis in non-cirrhotic liver: a case report.

  2003cites this paper
• Oxyradicals in Iron Overload Syndromes: Hemochromatosis

  2003cites this paper
• Clinique, diagnostic et traitement de l'hémochromatose héréditaire

  2002cites this paper
• Iron and carcinogenesis: from Fenton reaction to target genes

  2002cites this paper
• Hepatoma in a 40-year old male with hereditary hemochromatosis in the absence of cirrhosis. Implications of molecular diagnosis.

  2002cites this paper
• Carcinoma hepatocelular en una paciente afectada de hemocromatosis hereditaria sin cirrosis

  2001cites this paper
• Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease

  2001cites this paper
• Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.

  2001cites this paper
• [Hepatocellular carcinoma in a patient with hereditary hemochromatosis without cirrhosis].

  2001cites this paper
• [Iron overload and cancer].

  2000cites this paper
• Hepatocellular Carcinoma Arising in Non-Cirrhotic Liver in Genetic Haemochromatosis

  2000influential citation
• Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis

  2000cites this paper
• Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.

  2000cites this paper
• [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].

  2000cites this paper
• Cholangiocarcinoma arising in Von Meyenburg complex associated with hepatocellular carcinoma in genetic haemochromatosis.

  2000cites this paper
• Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.

  1999cites this paper
• Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.

  1999cites this paper
• Diagnosis and Management of Hereditary Hemochromatosis

  1999cites this paper
• Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.

  1999cites this paper
• Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation.

  1999cites this paper
• Management of Hemochromatosis

  1998cites this paper
• Clinical management of iron overload.

  1998cites this paper
• Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis.

  1998cites this paper
• Hepatocellular carcinoma in a non-cirrhotic coal miner with secondary haemochromatosis.

  1997cites this paper
• Epidemiological characteristics and risk factors of hepatocellular carcinoma

  1997cites this paper
• Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis.

  1996cites this paper
• [Cholangiocarcinoma in genetic hemochromatosis].

  1996cites this paper
• Long-term survival in patients with hereditary hemochromatosis.

  1996cites this paper
• Iron-induced carcinogenesis: the role of redox regulation.

  1996cites this paper
• Anatomopathologie des cirrhoses hépatiques et des lésions prénéoplasiques

  1996cites this paper
• Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver

  1995cites this paper
• The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis

  1995cites this paper
• Hepatocellular carcinoma and African iron overload.

  1995cites this paper
• Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark

  1995cites this paper
• Etiologies, consequences, and treatment of iron overload.

  1994cites this paper
• Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis

  1994cites this paper
• Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

  1993cites this paper
• Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice

  1992cites this paper
• Hepatocellular carcinoma.

  1992cites this paper
• Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis

  1992cites this paper
• Clinical presentation of hemochromatosis: a changing scene.

  1991cites this paper
• Iron in the pathogenesis of hepatocellular carcinoma.

  1991cites this paper
• Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver.

  1991cites this paper
• Hemochromatosis 1991. What will increased clinical screening mean for medical directors?

  1991cites this paper
• Hepatic diseases in the elderly.

  1990cites this paper
• The pathology of hepatic iron overload: A free radical‐Mediated Process?

  1990cites this paper